Pancreatoduodenectomy with artery-first approach.


Journal

Minerva chirurgica
ISSN: 1827-1626
Titre abrégé: Minerva Chir
Pays: Italy
ID NLM: 0400726

Informations de publication

Date de publication:
Jun 2019
Historique:
pubmed: 3 1 2019
medline: 21 12 2019
entrez: 3 1 2019
Statut: ppublish

Résumé

"Artery-first approach" encompasses different aspects for the surgical treatment of pancreatic cancer. It is a surgical technique or set of techniques which share in common the dissection of the main arterial vasculature involved in pancreatic cancer, before any irreversible surgical step is performed. On the other hand it represents the need for a meticulous dissection of the arterial planes and clearing of the retropancreatic tissue between the superior mesenteric artery, the common hepatic artery and portal vein in an attempt to achieve R0 resections. The recent expansion of this approach is based mainly on three factors: venous involvement should not be considered a contraindication for resection, most of the pancreatic resections performed with a standard procedure may be in fact non-oncological (R1) resections and the postero-medial or vascular margin is the most frequently invaded by the tumor. This review aimed to summarize and update the artery-first approach in pancreaticoduodenectomy.

Identifiants

pubmed: 30600965
pii: S0026-4733.18.07944-0
doi: 10.23736/S0026-4733.18.07944-0
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

226-236

Auteurs

Isabel Mora-Oliver (I)

Liver, Biliary and Pancreatic Unit, Department of General Surgery, Hospital Clínico, University of Valencia, Spain.
Biomedical Research Institute INCLIVA, Valencia, Spain.

Marina Garcés-Albir (M)

Liver, Biliary and Pancreatic Unit, Department of General Surgery, Hospital Clínico, University of Valencia, Spain.
Biomedical Research Institute INCLIVA, Valencia, Spain.

Dimitri Dorcaratto (D)

Liver, Biliary and Pancreatic Unit, Department of General Surgery, Hospital Clínico, University of Valencia, Spain.
Biomedical Research Institute INCLIVA, Valencia, Spain.

Elena Muñoz-Forner (E)

Liver, Biliary and Pancreatic Unit, Department of General Surgery, Hospital Clínico, University of Valencia, Spain.
Biomedical Research Institute INCLIVA, Valencia, Spain.

Ana Izquierdo Moreno (A)

Liver, Biliary and Pancreatic Unit, Department of General Surgery, Hospital Clínico, University of Valencia, Spain.
Biomedical Research Institute INCLIVA, Valencia, Spain.

Mari P Carbonell-Aliaga (MP)

Liver, Biliary and Pancreatic Unit, Department of General Surgery, Hospital Clínico, University of Valencia, Spain.
Biomedical Research Institute INCLIVA, Valencia, Spain.

Luis Sabater (L)

Liver, Biliary and Pancreatic Unit, Department of General Surgery, Hospital Clínico, University of Valencia, Spain - luis.sabater@uv.es.
Biomedical Research Institute INCLIVA, Valencia, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH